Publications
Publications
- May 2024
- Journal of the American College of Radiology
True Costs of Uterine Artery Embolization: Time-Driven Activity-Based Costing in Interventional Radiology Over a 3-Year Period
By: Julia C. Bulman, Nicole H. Kim, Robert S. Kaplan, Sarah Schroeppel DeBacker, Olga R. Brook and Ammar Sarwar
Abstract
The study used time-driven activity-based costing (TDABC) to estimate the costs to perform uterine artery embolization (UAE). Utilization times for patients undergoing outpatient UAE for fibroids or adenomyosis were captured from electronic health record timestamps and staff interviews. Capacity cost rates were estimated using institutional data and manufacturer proxy prices. Costs were calculated using TDABC for personnel, equipment, and consumables. The mean total cost of UAE was $4,267, with the greatest contributor being consumables (51%), followed by personnel (33%), and equipment (7%). Embolic agents accounted for 51% of consumable costs, followed by vascular devices (15%). The cost of embolic agents was driven mainly by the number of vials used.
Keywords
Citation
Bulman, Julia C., Nicole H. Kim, Robert S. Kaplan, Sarah Schroeppel DeBacker, Olga R. Brook, and Ammar Sarwar. "True Costs of Uterine Artery Embolization: Time-Driven Activity-Based Costing in Interventional Radiology Over a 3-Year Period." Journal of the American College of Radiology 21, no. 5 (May 2024): 721–728.